WEST VIRGINIA UNIVERSITY

MeiraGTx's AAV-GAD gene therapy for Parkinson's disease showed significant safety and efficacy in a small phase 1/2 study, prompting plans for a pivotal trial. The therapy, administered via subthalamic nucleus infusion, demonstrated clinically meaningful improvements in motor function and quality of life scores.

Members of the US Pancreatic Disease Study Group include C. Mel Wilcox, Ji Young Bang, Akwi Asombang, Chloe Bennett, Yan Bi, Wojciech Blogowski, James Buxbaum, Wei-Shen Chin, Darwin Conwell, Gregory A. Coté, Timothy B. Gardner, Pramod Garg, Nalini Guda, Robert Hawes, Yasmin G. Hernandez-Barco, Emily Jonica, Prashant Kedia, Thomas Kowalski, Vivek Kumbhari, Linda Lee, Jorge Machicado, Desiree Morgan, Thiruvengadam Muniraj, Udayakumar Navaneethan, Veeral Oza, Swati Pawa, Rajesh Puri, Amit Rastogi, D. Nageshwar Reddy, Monica Saumoy, Mandeep Sawhney, Santhi Swaroop Vege, Rupjyoti Talukdar, Paul Tarnasky, Felix Tellez-Avila, Shyam Thakkar, Nikhil Thiruvengadam, Elaina Vivian, Irving Waxman, Field F. Willingham, Shyam Varadarajulu.

NIH selects OHSU, UW, and WVU as inaugural hubs for CARE for Health, a primary care–focused clinical research network aiming to improve access to clinical research for underserved communities. The $30 million initiative will engage rural communities in existing NIH-funded studies on pain management, polysubstance abuse, and gout, with the goal of improving patient outcomes and expanding research opportunities.

Precision Neuroscience’s Layer 7 Cortical Interface, with 1,024 electrodes, captures unprecedented neural patterns in motor cortex, revealing beta wave dynamics during movement, potentially revolutionizing BCI technology and neurological treatments.

Precision Neuroscience's Layer 7 Cortical Interface enables unprecedented brain signal mapping, decoding movement and speech with high accuracy, advancing brain-computer interface technology.

Jonathan H. Sherman, MD, FAANS, FCNS, FACS, has been appointed as chief of Neurosurgical Oncology at Rutgers Cancer Institute, New Jersey's only National Cancer Institute-designated Comprehensive Cancer Center, and RWJBarnabas Health. Dr. Sherman, an expert in brain and spinal tumors, will also serve as a professor at Rutgers Robert Wood Johnson Medical School and on the medical staff at Robert Wood Johnson University Hospital. He aims to develop a robust research and clinical trials program in New Jersey.